Related Experiment Video
Updated: Jul 11, 2026
09:09
Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
Published on: May 2, 2019
Nucleoside analogue delivery systems in cancer therapy
Roudayna Diab1, Ghania Degobert, Misara Hamoudeh
1School of Pharmacy, Université Lyon 1-ESCPE - UMR 5007, Laboratoire d'Automatique et de Génie des Procédés, Bât. 308 G, 43, Bd du 11 Novembre 1918, 69622 Villeurbanne Cedex, France.
Expert Opinion on Drug Delivery
|September 21, 2007
Summary
Nucleoside analogues (NAs) show promise for treating blood cancers but face challenges like toxicity and poor drug distribution. Novel delivery systems aim to improve NA efficacy by targeting cancer cells and reducing side effects.
Area of Science:
- Oncology
- Pharmacology
- Biomaterials Science
Background:
- Nucleoside analogues (NAs) are crucial in treating hematological malignancies.
- NAs function as prodrugs requiring intracellular phosphorylation for activation.
- Challenges include rapid metabolism, drug resistance, and systemic distribution, leading to high doses, toxicity, and a narrow therapeutic index.
Purpose of the Study:
- To review novel drug delivery systems for nucleoside analogues.
- To discuss emerging technologies for enhancing NA cancer therapy.
- To address the challenge of concentrating NAs at tumor sites while minimizing distribution to healthy tissues.
Main Methods:
- Literature review of recent advancements in NA delivery systems.
- Analysis of new biomaterials and drug carrier technologies.
- Discussion of strategies to improve tumor-specific drug accumulation.
Main Results:
- Emerging drug carriers and biomaterials show potential for overcoming NA limitations.
- New technologies offer improved methods for targeted NA delivery.
- Strategies focus on enhancing drug concentration at tumor sites.
Conclusions:
- Novel delivery systems and technologies are critical for improving nucleoside analogue efficacy in cancer treatment.
- Targeted delivery can mitigate toxicity and broaden the therapeutic index of NAs.
- Further development in drug delivery is essential for advancing NA-based chemotherapy.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...